Natera | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Social & Marketing
Video & Media
Email & Communication
Keywords & Focus Areas
Natera
Overview
Natera, Inc. is a leader in cell-free DNA (cfDNA) testing, focusing on genetic testing and diagnostics in oncology, women's health, and organ health. Founded in 2004 and based in Austin, Texas, the company utilizes advanced molecular biology techniques and proprietary bioinformatics software to deliver accurate, noninvasive genetic tests. Its mission is to integrate personalized genetic testing into standard healthcare practices, aiming to improve patient outcomes and extend healthy lives.
The company offers a wide range of cfDNA-based tests, including Signatera™ for cancer monitoring, Panorama™ for noninvasive prenatal screening, and Prospera™ for assessing kidney transplant rejection risk. Other offerings include Aletra™ for genomic profiling, Renasight™ for kidney disease detection, and Empower™ for hereditary cancer risk assessment. Its technology platform holds over 250 patents supporting a strong commitment to innovation and clinical validation, with extensive support for patients and healthcare providers.
Basic Information
| Industry | research |
|---|---|
| Founded | 2004 |
| Revenue | 1.8B |
| Headquarters | 13011A McCallen Pass, Austin, Texas 78753, United States |
| Languages | English |
| Alexa Ranking | 129757 |
Contact Details
- Phone: +1 510-826-3572
- Website: natera.com
- LinkedIn: linkedin.com/company/natera
Key Focus Areas & Initiatives
- Noninvasive prenatal testing
- Single gene diseases
- Preimplantation genetic screening
- Diagnosis
- Biopsy training
- Multidisease carrier screening
- Bioinformatics
- Miscarriage testing
- Genetic counseling
- Oncology
- Colorectal cancer
- Transplant rejection testing
- Hereditary cancer gene panels
- Organ health assessment
- Molecular residual disease
- Prenatal genetic screening
- Tumor-informed ctDNA
- Organ transplant monitoring
- Patient-centered diagnostics
- Clinical validation
- Genetic testing
- Liquid biopsy assays
- Patient outcome improvement
- Non-invasive diagnostics
- Clinical trial data
- Genomic profiling
- Diagnostic accuracy
- Genetic biomarkers
- AI in diagnostics
- Personalized medicine
- Molecular diagnostics
- Personalized treatment planning
- Clinical genomics
- Support for patients and providers
- Healthcare technology innovation
- Molecular tumor profiling
- Laboratory quality standards
- Genomic data integration
- Cancer biomarker discovery
- Genomic mutation analysis
Technologies Used
- Adobe Media Optimizer
- Amazon AWS
- Atlassian Cloud
- Atlassian Confluence
- Cedexis Radar
- Cloudinary
- DemandBase
- DoubleClick Floodlight
- Drupal
- Eloqua
- Facebook Custom Audiences
- Facebook Login (Connect)
- Facebook Widget
- Gmail
- Google AdWords Conversion
- Google Analytics
- Google Apps
- Google Tag Manager
- Greenhouse.io
- HeapAnalytics
- Hubspot
- Jira
- KISSmetrics
- Linkedin Marketing Solutions
- LiveRamp
- Microsoft Office 365
- Mobile Friendly
- Multilingual
- Nginx
- Oracle Cloud
- Remote
- Route 53
- SOASTA
- Salesforce
- Stripe
- Vimeo
- Wistia
- WordPress.org
- reCAPTCHA